• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇耗竭抑制利妥昔单抗交联诱导的src家族激酶依赖性钙动员和细胞凋亡。

Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking.

作者信息

Unruh Tammy L, Li Haidong, Mutch Cathlin M, Shariat Neda, Grigoriou Lana, Sanyal Ratna, Brown Christopher B, Deans Julie P

机构信息

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.

出版信息

Immunology. 2005 Oct;116(2):223-32. doi: 10.1111/j.1365-2567.2005.02213.x.

DOI:10.1111/j.1365-2567.2005.02213.x
PMID:16162271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1817827/
Abstract

The monoclonal antibody (mAb) rituximab produces objective clinical responses in patients with B-cell non-Hodgkin's lymphoma and antibody-based autoimmune diseases. Mechanisms mediating B-cell depletion by rituximab are not completely understood and may include direct effects of signalling via the target antigen CD20. Like most but not all CD20 mAbs, rituximab induces a sharp change in the solubility of the CD20 protein in the non-ionic detergent Triton-X-100, reflecting a dramatic increase in the innate affinity of CD20 for membrane raft signalling domains. Apoptosis induced by rituximab hypercrosslinking has been shown to require src family kinases (SFK), which are enriched in rafts. In this report we provide experimental evidence that SFK-dependent apoptotic signals induced by rituximab are raft dependent. Cholesterol depletion prevented the association of hypercrosslinked CD20 with detergent-insoluble rafts, and attenuated both calcium mobilization and apoptosis induced with rituximab. CD20 cocapped with the raft-associated transmembrane adaptor LAB/NTAL after hypercrosslinking with CD20 mAbs, regardless of their ability to induce a change in the affinity of CD20 for rafts. Taken together, the data demonstrate that CD20 hypercrosslinking via rituximab activates SFKs and downstream signalling events by clustering membrane rafts in which antibody-bound CD20 is localized in a high-affinity configuration.

摘要

单克隆抗体(mAb)利妥昔单抗可使B细胞非霍奇金淋巴瘤患者和基于抗体的自身免疫性疾病患者产生客观的临床反应。利妥昔单抗介导B细胞耗竭的机制尚未完全明确,可能包括通过靶抗原CD20进行信号传导的直接作用。与大多数(但并非全部)CD20单克隆抗体一样,利妥昔单抗可使CD20蛋白在非离子去污剂Triton-X-100中的溶解度发生急剧变化,这反映出CD20对膜筏信号结构域的固有亲和力显著增加。已证明利妥昔单抗过度交联诱导的细胞凋亡需要src家族激酶(SFK),而SFK在筏中含量丰富。在本报告中,我们提供了实验证据,证明利妥昔单抗诱导的依赖SFK的凋亡信号是依赖筏的。胆固醇耗竭可阻止过度交联的CD20与去污剂不溶性筏的结合,并减弱利妥昔单抗诱导的钙动员和细胞凋亡。用CD20单克隆抗体过度交联后,CD20与筏相关跨膜衔接子LAB/NTAL共帽,无论其是否能够诱导CD20对筏的亲和力发生变化。综上所述,数据表明通过利妥昔单抗进行的CD20过度交联通过聚集膜筏激活SFK和下游信号事件,其中抗体结合的CD20以高亲和力构型定位在膜筏中。

相似文献

1
Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking.胆固醇耗竭抑制利妥昔单抗交联诱导的src家族激酶依赖性钙动员和细胞凋亡。
Immunology. 2005 Oct;116(2):223-32. doi: 10.1111/j.1365-2567.2005.02213.x.
2
Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.美罗华(抗CD20抗体)诱导的CD20易位至脂筏对于钙内流和细胞凋亡至关重要。
Clin Exp Immunol. 2005 Mar;139(3):439-46. doi: 10.1111/j.1365-2249.2005.02720.x.
3
Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis.簇集的CD20诱导细胞凋亡:src家族激酶,酪氨酸磷酸化、钙内流和半胱天冬酶3依赖性细胞凋亡的近端调节因子。
Blood Cells Mol Dis. 2000 Apr;26(2):133-43. doi: 10.1006/bcmd.2000.0287.
4
Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels.淋巴瘤细胞系中利妥昔单抗耐药性的获得与转录前和转录后水平调控的整体CD20基因及蛋白下调均相关。
Clin Cancer Res. 2008 Mar 1;14(5):1561-70. doi: 10.1158/1078-0432.CCR-07-1254.
5
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.利妥昔单抗(美罗华,抗CD20单克隆抗体)在非霍奇金淋巴瘤中调节的细胞和分子信号转导途径:对化疗增敏和治疗干预的影响。
Oncogene. 2005 Mar 24;24(13):2121-43. doi: 10.1038/sj.onc.1208349.
6
Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.抗CD20治疗性抗体利妥昔单抗可改变B淋巴瘤细胞筏/微结构域的功能组织。
Cancer Res. 2003 Jan 15;63(2):534-40.
7
The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis.自体亲合性抗 CD20 抗体 DXL625 通过脂筏依赖性诱导细胞凋亡而显示出增强的效力。
Anticancer Drugs. 2010 Jun;21(5):532-42. doi: 10.1097/CAD.0b013e328337d485.
8
Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.具有改变的细胞信号传导和对化疗交叉耐药性的利妥昔单抗耐药淋巴瘤克隆的发展。
Cancer Res. 2007 Feb 1;67(3):1270-81. doi: 10.1158/0008-5472.CAN-06-2184.
9
CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts.CD20诱导的淋巴瘤细胞死亡既不依赖于半胱天冬酶,也不依赖于其重新分布到不溶于曲拉通X-100的膜筏中。
Cancer Res. 2003 Sep 1;63(17):5480-9.
10
Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.抗CD20-澳瑞他汀偶联物有效消除B细胞系淋巴瘤
Clin Cancer Res. 2004 Dec 1;10(23):7842-51. doi: 10.1158/1078-0432.CCR-04-1028.

引用本文的文献

1
Ca Signaling and Src Functions in Tumor Cells.钙信号转导和肿瘤细胞中的Src 功能。
Biomolecules. 2023 Dec 3;13(12):1739. doi: 10.3390/biom13121739.
2
Cell-surface photochemistry mediated calcium overload for synergistic tumor therapy.基于细胞膜表面光化学反应的钙超载协同肿瘤治疗
J Nanobiotechnology. 2023 Sep 19;21(1):335. doi: 10.1186/s12951-023-02090-z.
3
Cyto-friendly polymerization at cell surfaces modulates cell fate by clustering cell-surface receptors.细胞表面的细胞友好型聚合通过聚集细胞表面受体来调节细胞命运。
Chem Sci. 2020 Mar 25;11(16):4221-4225. doi: 10.1039/c9sc06385d.
4
Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature.抗CD20疗法在滤泡性和边缘区淋巴瘤中的应用:文献综述
Drugs Context. 2020 May 6;9. doi: 10.7573/dic.2019-9-3. eCollection 2020.
5
Pemphigus: Current and Future Therapeutic Strategies.天疱疮:当前和未来的治疗策略。
Front Immunol. 2019 Jun 25;10:1418. doi: 10.3389/fimmu.2019.01418. eCollection 2019.
6
Drug-free albumin-triggered sensitization of cancer cells to anticancer drugs.无药物白蛋白触发癌细胞对抗癌药物的敏感性。
J Control Release. 2019 Jan 10;293:84-93. doi: 10.1016/j.jconrel.2018.11.015. Epub 2018 Nov 19.
7
Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.利妥昔单抗的过去、现在与未来——全球首个肿瘤学单克隆抗体疗法
Front Oncol. 2018 Jun 4;8:163. doi: 10.3389/fonc.2018.00163. eCollection 2018.
8
Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.利妥昔单抗耐药 B 淋巴细胞瘤细胞中 CD20 交联的扩增增强了无药物大分子治疗药物诱导的细胞凋亡。
ACS Nano. 2018 Apr 24;12(4):3658-3670. doi: 10.1021/acsnano.8b00797. Epub 2018 Apr 2.
9
Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway.无药物大分子治疗通过钙内流和线粒体信号通路诱导细胞凋亡。
Macromol Biosci. 2018 Jan;18(1). doi: 10.1002/mabi.201700196. Epub 2017 Aug 14.
10
Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.无药大分子疗法——聚合物纳米药物的新范例
Biomater Sci. 2015 Jul;3(7):908-22. doi: 10.1039/C4BM00442F.

本文引用的文献

1
Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.美罗华(抗CD20抗体)诱导的CD20易位至脂筏对于钙内流和细胞凋亡至关重要。
Clin Exp Immunol. 2005 Mar;139(3):439-46. doi: 10.1111/j.1365-2249.2005.02720.x.
2
Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab.以Bcl-2蛋白表达为靶点的寡核苷酸Genasense(奥布力默生钠)进行的促凋亡治疗可增强利妥昔单抗的生物抗肿瘤活性。
Br J Haematol. 2004 Dec;127(5):519-30. doi: 10.1111/j.1365-2141.2004.05239.x.
3
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines.利妥昔单抗在人B淋巴瘤细胞系中诱导出不同但有重叠的基因集。
Cancer Immunol Immunother. 2005 Mar;54(3):273-86. doi: 10.1007/s00262-004-0599-4. Epub 2004 Sep 23.
4
From the bench to the bedside: ways to improve rituximab efficacy.从实验室到临床:提高利妥昔单抗疗效的方法。
Blood. 2004 Nov 1;104(9):2635-42. doi: 10.1182/blood-2004-03-1110. Epub 2004 Jun 29.
5
Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains.利妥昔单抗在B淋巴瘤细胞中的抗增殖作用与脂筏微结构域中酸性鞘磷脂酶的激活有关。
Blood. 2004 Aug 15;104(4):1166-73. doi: 10.1182/blood-2004-01-0277. Epub 2004 May 4.
6
Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia.利妥昔单抗输注可促进慢性淋巴细胞白血病患者快速补体耗竭及急性CD20丢失。
J Immunol. 2004 Mar 1;172(5):3280-8. doi: 10.4049/jimmunol.172.5.3280.
7
The CD20 calcium channel is localized to microvilli and constitutively associated with membrane rafts: antibody binding increases the affinity of the association through an epitope-dependent cross-linking-independent mechanism.CD20钙通道定位于微绒毛,且与膜筏组成性相关:抗体结合通过一种不依赖表位交联的机制增加这种结合的亲和力。
J Biol Chem. 2004 May 7;279(19):19893-901. doi: 10.1074/jbc.M400525200. Epub 2004 Feb 19.
8
Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents.抗体特异性控制抗CD20试剂的体内效应机制。
Blood. 2004 Apr 1;103(7):2738-43. doi: 10.1182/blood-2003-06-2031. Epub 2003 Oct 9.
9
CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts.CD20诱导的淋巴瘤细胞死亡既不依赖于半胱天冬酶,也不依赖于其重新分布到不溶于曲拉通X-100的膜筏中。
Cancer Res. 2003 Sep 1;63(17):5480-9.
10
Store-operated cation entry mediated by CD20 in membrane rafts.由CD20介导的膜筏中的储存式阳离子内流。
J Biol Chem. 2003 Oct 24;278(43):42427-34. doi: 10.1074/jbc.M308802200. Epub 2003 Aug 14.